Evidence map›Paper›PMID 17554062›Full record

ArticleBlood2007

Lipid rafts are required for Kit survival and proliferation signals.

Thomas Jahn, Erica Leifheit, Stacie Gooch, Simran Sindhu, Kenneth Weinberg

Open access · greenAbstract read
In one paragraph

Article in Blood, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Proteomic Analysis of Lipid Rafts from RBL-2H3 Mast Cells.International journal of molecular sciences · 2019
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Thomas JahnDivision of Research Immunology and Bone Marrow Transplantation, Childrens Hospital Los Angeles, CA, USA. thahn@stanford.edu
Erica Leifheit
Stacie Gooch
Simran Sindhu
Kenneth Weinberg
Children's Hospital of Los Angeles · US

Funding

IL-7R and c-kit interactions in thymopoiesisR01AI050765 · NIAID · STANFORD UNIVERSITY · PI WEINBERG, KENNETH I. · 2002 to 2006
$1.9M
ENHANCEMENT OF POST-BMT IMMUNE RECONSTITUTION BY IL-7R01HL054729 · NHLBI · STANFORD UNIVERSITY · PI WEINBERG, KENNETH I. · 1996 to 2006
$1.5M
NHLBI NIH HHS HL54729NHLBI NIH HHS R01 HL054729NIAID NIH HHS AI50765NIAID NIH HHS R01 AI050765
6 · The paper itself

Abstract

In addition to its physiologic role as central regulator of the hematopoietic and reproductive systems, the Kit receptor tyrosine kinase (RTK) is pathologically overexpressed in some forms of leukemia and constitutively activated by oncogenic mutations in mast-cell proliferations and gastrointestinal stromal tumors. To gain insight into the general activation and signaling mechanisms of RTKs, we investigated the activation-dependent dynamic membrane distributions of wild-type and oncogenic forms of Kit in hematopoietic cells. Ligand-induced recruitment of wild-type Kit to lipid rafts after stimulation by Kit ligand (KL) and the constitutive localization of oncogenic Kit in lipid rafts are necessary for Kit-mediated proliferation and survival signals. KL-dependent and oncogenic Kit kinase activity resulted in recruitment of the regulatory phosphatidylinositol 3-kinase (PI3-K) subunit p85 to rafts where the catalytical PI3-K subunit p110 constitutively resides. Cholesterol depletion by methyl-beta-cyclodextrin prevented Kit-mediated activation of the PI3-K downstream target Akt and inhibited cellular proliferation by KL-activated or oncogenic Kit, including mutants resistant to the Kit inhibitor imatinib-mesylate. Our data are consistent with the notion that Kit recruitment to lipid rafts is required for efficient activation of the PI3-K/Akt pathway and Kit-mediated proliferation.

Indexed as

Cell ProliferationCell SurvivalAnimalsBenzamidesbeta-CyclodextrinsCells, CulturedCholesterolCytosolHematopoietic Stem CellsHumansImatinib MesylateKineticsMast CellsMembrane MicrodomainsMiceMutationBenzamidesbeta-CyclodextrinsCholesterolImatinib Mesylatemethyl-beta-cyclodextrinPhosphatidylinositol 3-KinasesPiperazinesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktProto-Oncogene Proteins c-kitPTEN PhosphohydrolasePyrimidinesPyruvate Dehydrogenase Acetyl-Transferring KinaseStem Cell Factor

Identifiers

PMID17554062
PMCPMC1976347
OpenAlexW2015301339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.